AAL

Viking Therapeutics Stock Soars on Successful Trial

VKTX already boasts an impressive 360% lead for 2024

Digital Content Manager
Mar 26, 2024 at 10:43 AM
facebook X logo linkedin


Viking Therapeutics Inc (NASDAQ:VKTX) is skyrocketing today, last seen up 22.3% at $84.62. The company said an early-stage trial of its experimental weight-loss tablet helped reduce patients' weight, while proving to be safe and effective, and that it will initiate a phase 2 trial later this year.

So far today, 33,000 calls and 16,000 puts have already traded hands, which is six times the volume typically seen at this point. The most popular contract is the weekly 3/28 100-strike call.

A continued sentiment shift in the options pits could generate even more tailwinds, as the equity's Schaeffer’s open interest ratio (SOIR) sits the 86th percentile of its 12-month range. This means short-term options traders leaned bearish coming into today. Plus, the shares look ripe for a short squeeze, with 11.9% of their available float sold short. 

The security is pivoting higher from the $60, after pulling back from its Feb. 28, record high of $99.41. The security is today looking to snap a three-day losing streak with is best single-day percentage gain since February, and boasts an impressive 360% lead so far this year.

 

Same-Day Trading Power: +227% YTD and Counting  — Get in for $10!

We're celebrating 44 years of helping traders win, and you can now tap into one of our most explosive services — Dynamite Day Trading Signals — for just $10.

This service was built for one thing: capturing intraday gains with precision. 

Access two highly-vetted options trades each week -  Complete with defined entries, exits, and a clear plan for same-day profits.

👉 Click Here to Learn More and Position Yourself to Take Action When the Next Alert Hits.